Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children

Registry ID

EUCTR2015-003536-12

Source registry

EUCTR

Phase

PHASE3

Sponsor

Novartis Pharmaceuticals

Last update

2026-08-16

Conditions

• Allergic Asthma

Summary

To assess the long-term safety and tolerability of omalizumab by measuring AEs, serious AEs, physical examination, medical history, laboratory assessments and vital signs

Related clinical trials

• Asthma Inflammation Research
• Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study
• Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma
• ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
• Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients
• Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma

View on source registry